Clinical Trial of a Selective Estrogen Receptor Modulator (raloxifene) in the treatment of cognitive deficits and psychotic symptoms of patients with schizophrenia
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Raloxifene (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms CASSI
- 26 Aug 2013 New trial record